Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art by Florence Lerebours, Luc Cabel, Jean-Yves Pierga

Get full text

Clinical utility of circulating tumor cells: an update by Antoine Vasseur, Nicolas Kiavue, François‐Clément Bidard, Jean‐Yves Pierga, Luc Cabel

Get full text

Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study by Benjamin Nicaise, Pierre Loap, Delphine Loirat, Fatima Laki, Jean-Yves Pierga, Alain Fourquet, Youlia Kirova

Get full text

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis. by Julie Labrosse, Marie Osdoit, Anne-Sophie Hamy, Florence Coussy, Jean-Yves Pierga, Fabien Reyal, Enora Laas

Get full text

HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer by Afroditi Nanou, Leonie Laura Zeune, Francois-Clement Bidard, Jean-Yves Pierga, Leonardus Wendelinus Mathias Marie Terstappen

Get full text

Neoadjuvant Concurrent Radiotherapy and Chemotherapy in Early Breast Cancer Patients: Long-Term Results of a Prospective Phase II Trial by Diane Jornet, Pierre Loap, Jean-Yves Pierga, Fatima Laki, Anne Vincent-Salomon, Youlia M. Kirova, Alain Fourquet

Get full text

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population. by Lea Rossi, Denise Stevens, Jean-Yves Pierga, Florence Lerebours, Fabien Reyal, Mathieu Robain, Bernard Asselain, Roman Rouzier

Get full text

Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer by Mercedes Tkach, Caroline Hego, Marc Michel, Lauren Darrigues, Jean‐Yves Pierga, François‐Clément Bidard, Clotilde Théry, Charlotte Proudhon

Get full text

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVAS... by Renaud Sabatier, Jean-Yves Pierga, Hervé Curé, Rakan Abulnaja, Eric Lambaudie, François-Clément Bidard, Jean-Marc Extra, Patrick Sfumato, Anthony Gonçalves

Get full text

A DNA methylation-based liquid biopsy for triple-negative breast cancer by Katrina Cristall, Francois-Clement Bidard, Jean-Yves Pierga, Michael J. Rauh, Tatiana Popova, Clara Sebbag, Olivier Lantz, Marc-Henri Stern, Christopher R. Mueller

Get full text

Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival by Chantal Bourrier, Jean-Yves Pierga, Laura Xuereb, Hélène Salaun, Charlotte Proudhon, Michael R. Speicher, Jelena Belic, Ellen Heitzer, Brian Paul Lockhart, Nolwen Guigal-Stephan

Get full text

Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study. by Françoise Laroche, Serge Perrot, Terkia Medkour, Paul-Henri Cottu, Jean-Yves Pierga, Jean-Pierre Lotz, Karine Beerblock, Christophe Tournigand, Laure Chauvenet, Didier Bouhassira, Joël Coste

Get full text

Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery. by Marie Gosset, Anne-Sophie Hamy, Peter Mallon, Myriam Delomenie, Delphine Mouttet, Jean-Yves Pierga, Marick Lae, Alain Fourquet, Roman Rouzier, Fabien Reyal, Jean-Guillaume Feron

Get full text

Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic Approach by Ezgi Tulukcuoglu Guneri, Emile Lakis, Ismail Hajji, Elian Martin, Jerome Champ, Aurore Rampanou, Jean-Yves Pierga, Jean-Louis Viovy, Charlotte Proudhon, François-Clément Bidard, Stéphanie Descroix

Get full text

Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals by Clelia Chalumeau, Matthieu Carton, Alexandre Eeckhoutte, Stelly Ballet, Anne Vincent-Salomon, Perrine Vuagnat, Audrey Bellesoeur, Jean-Yves Pierga, Marc-Henri Stern, Francois-Clement Bidard, Florence Lerebours

Get full text

<i>HER2</i>-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant Chemotherapy Plus Trastuz... by Enora Laas, Arnaud Bresset, Jean-Guillaume Féron, Claire Le Gal, Lauren Darrigues, Florence Coussy, Beatriz Grandal, Lucie Laot, Jean-Yves Pierga, Fabien Reyal, Anne-Sophie Hamy

Get full text

Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach. by Enora Laas, Anne-Sophie Hamy, Anne-Sophie Michel, Nabilah Panchbhaya, Matthieu Faron, Thanh Lam, Sophie Carrez, Jean-Yves Pierga, Roman Rouzier, Florence Lerebours, Jean-Guillaume Feron, Fabien Reyal

Get full text

Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Me... by Anne Brédart, Aude Rault, Johanna Terrasson, Etienne Seigneur, Leanne De Koning, Elisabeth Hess, Alexia Savignoni, Paul Cottu, Jean-Yves Pierga, Sophie Piperno-Neumann, Manuel Rodrigues, Carole Bouleuc, Sylvie Dolbeault

Get full text

Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma. by Fabien Reyal, Marc A Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau

Get full text

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma. by Fabien Reyal, Marc A. Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau

Get full text